Finally, we overexpressed and knocked down LAMB3 in prostate cancer cells using lentiviral plasmid transfection, followed by functional experiments to validate LAMB3 as a tumor suppressor gene that inhibits prostate cancer progression. Here, LAMB3 is linked to prostate carcinoma.